AnaptysBio (ANAB) is Initiated by Wedbush to “Outperform”

AnaptysBio (ANAB) was Initiated by Wedbush to “Outperform” and the brokerage firm has set the Price Target at $28. Wedbush advised their Clients and Investors in a research report released on Feb 21, 2017.

Based on several research reports , Credit Suisse Initiated AnaptysBio on Feb 21, 2017 to “Outperform”, Price Target of the shares are set at $34.Stifel Initiated AnaptysBio on Feb 21, 2017 to “Buy”, Price Target of the shares are set at $30.

AnaptysBio

Add Comment